Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $58.22M June 30, 2014
Broadfin Capital 6.64M $28.60M June 30, 2014
Baker Bros. Advisors 4.45M $19.18M June 30, 2014
FMR 4.41M $18.02M March 31, 2014
BlackRock Fund Advisors 2.52M $13.06M Sept. 30, 2014
Tudor Investment Corporation 2.34M $9.58M March 31, 2014
BlackRock Institutional Trust Company, N.A. 2.34M $12.13M Sept. 30, 2014
Vanguard 1.92M $8.28M June 30, 2014
Highland Capital Management 1.59M $6.85M June 30, 2014
Wellington Management Company 1.57M $6.76M June 30, 2014
Deerfield Management Company 1.04M $5.60M March 31, 2013
STATE STREET CORPORATION 995936 $4.29M June 30, 2014
Phocas Financial 931880 $4.02M June 30, 2014
MORGAN STANLEY 850404 $3.67M June 30, 2014
NORTHERN TRUST 788855 $3.23M March 31, 2014
Taconic Capital Advisors 785982 $3.21M March 31, 2014
DIMENSIONAL FUND ADVISORS 681846 $2.94M June 30, 2014
Franklin Resources 636816 $2.60M March 31, 2014

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors Dec. 31, 2010 1.17M $6.38M